HCA Midwest Division — Kansas City, Missouri

HCA Midwest Division is a clinical research site located in Kansas City, Missouri, United States 64132.

Crixeo Clinical Trials Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

HCA Midwest Division has participated in 13 clinical trials with 4 currently active.

Therapeutic areas: Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer, Metastatic Prostate Cancer, Triple-negative Breast Cancer.

Sponsors: Hoffmann-La Roche, Bristol-Myers Squibb, Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for HCA Midwest Division?

HCA Midwest Division has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has HCA Midwest Division conducted?

HCA Midwest Division has 13 clinical trials on record, with 4 currently active. Their work covers Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer, Metastatic Prostate Cancer, Triple-negative Breast Cancer.

Is HCA Midwest Division accredited by Crixeo Clinical Trials?

HCA Midwest Division has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about HCA Midwest Division?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.